AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
Apr 28, 2011
30016_dirs_2011-04-28_e3a623ec-d102-4a84-8493-fcb66e74b376.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-04-26
Reporting Person: END WILLIAM T (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-04-26 | Common Stock | M | 8000 | $17.49 | Acquired | 31063 | Direct |
| 2011-04-27 | Common Stock | S | 7000 | $80.2697 | Disposed | 24063 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-04-26 | Non-Qualified Stock Option (right to buy) | $17.49 | M | 8000 | Disposed | 2013-05-21 | Common Stock (8000) | Direct |
Footnotes
F1: The $80.2697 price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $80.1780 to $80.5306, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F2: Grant of options to buy 8,000 shares of common stock that vest fully on the earlier of one year from the date of grant (05/21/2004) or the next annual meeting of stockholders.